neuroleptics

Allen Frances on the Benefits of “Antipsychotics”

March 11, 2016

On February 1, Allen Frances, MD, published an interesting article on the Huffington Post blog.  The article is called Do Antipsychotics Help or Harm Psychotic Symptoms?, and is a response to Robert Whitaker’s post of January 27:  “Me, Allen Frances, and Climbing Out of a Pigeonhole.  This post, in turn, was a response to Dr. […]

Read the rest →

Allen Frances ‘Replies’

June 24, 2015

BACKGROUND On June 19, 2015, I published a post titled Allen Frances’ Ties to Johnson & Johnson.  In that post, I set out some very serious allegations against Dr. Frances.  I drew these allegations from a document titled Special Witness Report dated October 15, 2010.  The report was written by David Rothman, PhD, Professor of […]

Read the rest →

Allen Frances’ Ties to Johnson & Johnson

June 19, 2015

INTRODUCTION I recently came across an article titled Diagnosisgate: Conflict of Interest at the Top of the Psychiatric Apparatus, by Paula Caplan, PhD.  The article was published in Aporia, the University of Ottawa nursing journal, in January 2015.  Aporia is “a peer-reviewed, bilingual, and open access journal dedicated to scholarly debates in nursing and the […]

Read the rest →

Neuroleptic Drugs And Mortality

June 1, 2015

In November of last year, the Schizophrenia Bulletin published online a research study:  Antipsychotic Treatment and Mortality in Schizophrenia, by Minna Torniainen et al.  The research was conducted in Sweden. The authors offer the following background for the study: “It is generally believed that long-term use of antipsychotics increases mortality and, especially, the risk of […]

Read the rest →

The Drugging of Children in Foster Care

March 16, 2015

It’s no secret that here in America, foster children are being prescribed psychiatric drugs, especially neuroleptics, as a means of controlling their behavior.  A great deal has been said and written on the matter.  Politicians have declared the practice deplorable.  Children’s advocacy groups have expressed concern, and, of course, those of us in the antipsychiatry […]

Read the rest →

Thomas Insel: “Are Children Overmedicated?”

February 10, 2015

Thomas Insel, MD, is the Director of the National Institute of Mental Health.  In June of last year, he published, on the Director’s Blog, an article titled Are Children Overmedicated?  The gist of the article is that children are not being overmedicated, but rather that there is an increase in “severe psychiatric problems” in this […]

Read the rest →

Second Generation Neuroleptics and Acute Kidney Injury in Older Adults

September 18, 2014

On August 19, 2014, the Annals of Internal Medicine published a paper titled Atypical Antipsychotic Drugs and the Risk for Acute Kidney Injury [AKI] and Other Adverse Outcomes in Older Adults.  The authors were Joseph Hwang et al, and the study was conducted at the Institute for Clinical Evaluative Sciences in Ontario, Canada.  The primary […]

Read the rest →

The Use of Neuroleptic Drugs as Chemical Restraints 

July 24, 2014

On July 17, I wrote a post on the use of neuroleptic drugs as chemical restraints in nursing homes.  The article generated some comments, one of which touched on some very fundamental issues which, in my view, warrant further discussion.  The comment was from drsusanmolchan and read as follows: “All drugs can be dangerous toxic […]

Read the rest →

The Use of Neuroleptic Drugs As Chemical Restraints in Nursing Homes

July 17, 2014

There’s an interesting article in the July-August 2014 issue of the AARP Bulletin.  It’s called Drug Abuse: Antipsychotics in Nursing Homes, and was written by Jan Goodwin.  AARP is the American Association of Retired Persons.   Jan Goodwin is an investigative journalist whose career, according to Wikipedia, “…has been committed to focusing attention on social justice […]

Read the rest →

Psychiatry Misusing the Political Process

March 30, 2014

On March 27, the US House of Representatives approved by a voice vote with no debate a Medicare bill, HR 4302, Protecting Access to Medicare Act of 2014.  The purpose of the bill is to avoid cutting Medicare payments to physicians, and there was, and is, general agreement on both side of the aisle that […]

Read the rest →

Involuntary Mental Health Commitments

March 20, 2014

The recent publicity surrounding the Justina Pelletier case has focused attention, not only on the spurious and arbitrary nature of psychiatric diagnoses, but also on the legitimacy and appropriateness of mental health commitments.  It is being widely asserted that these archaic statutes are fundamentally incompatible with current civil rights standards, and the question “should mental […]

Read the rest →

Neuroleptics and Tardive Dyskinesia in Children

February 26, 2014

There’s an interesting February 11, 2014, article on Peter Breggin’s website:  $1.5 Million Award in Child Tardive Dyskinesia Malpractice.  Thanks to Mad in America for the link. Here’s the opening paragraph: “On February 11, 2014 a Chicago jury awarded $1.5 million to an autistic child who developed a severe case of tardive dyskinesia and tardive […]

Read the rest →

Psychiatry’s Over Reliance On Pharma

January 3, 2014

I recently read The NIMH-CATIE Schizophrenia Study: What Did We Learn? by Jeffrey Lieberman, MD, and T. Scott Stroup, MD, MPH.  The article was published in the American Journal of Psychiatry 168:8, August 2011.   Here are two quotes: “When the CATIE study was designed in 1999-2000, the prevailing opinion of researchers and clinicians alike was […]

Read the rest →

Psychiatric Dogmatism

January 2, 2014

In November, Joanna Moncrieff, MD, a British psychiatrist who works as a Senior Lecturer in psychiatry at University College London and a practicing consultant psychiatrist, started her own blog.  What’s remarkable about this blog is that it is highly critical of psychiatry.  Dr. Moncrieff marshals important facts and arguments in this area, and it is […]

Read the rest →

CAFÉ Study: Real Science or Marketing Exercise?

December 18, 2013

BACKGROUND On December 8,  I received the following question from a reader:  (The subject matter is the controversial CAFÉ – Comparisons of Atypicals in First Episode of Psychosis – study.  This was the study in which Dan Markingson committed suicide.) “It appears that there was no head-to-head with a control group taking a placebo pill. […]

Read the rest →

Neuroleptics for Children: Harvard’s Shame

December 4, 2013

In December 2012, Mark Olfson, MD, et al, published an article in the Archives of General Psychiatry.  The title is National Trends in the Office-Based Treatment of Children, Adolescents, and Adults with Antipsychotics.  The authors collected data from the National Ambulatory Medical Care Surveys for the period 1993-2009, and looked for trends in antipsychotic prescribing […]

Read the rest →

Causes of High Mortality in People Labeled ‘Mentally Ill’

November 12, 2013

ANOTHER VIDEO FROM DR. LIEBERMAN On October 28, Jeffrey Lieberman, MD, President of the APA, made another video.  This one is titled An Important Look at Mortality in Mental Illness: A Decade of Data on Psychotropic Drugs, and was made for Medscape.  You can see the transcript at the same site.  Medscape is a web […]

Read the rest →

Pharma Corruption of Healthcare

October 9, 2013

I’ve been reading another great book:  Deadly Medicines and Organised Crime: How big pharma has corrupted healthcare, by Peter C. Gotzsche [Radcliffe Publishing, 2013]. The book is an exposé of pharma’s fraudulent research and marketing.  The author is a Danish physician who has been involved in clinical trials of drugs, and in drug regulatory matters.  He […]

Read the rest →

Second Generation Neuroleptics, Tardive Dyskinesia, and the Law

October 7, 2013

There’s an interesting article on Harvard Law Petrie-Flom Center’s blog titled Daubert as a Problem for Psychiatrists.  It was written by Alex Stein and is dated September 19.  [Thanks to Dustin Salzedo for drawing my attention to this in a comment on an earlier post.] The article deals with the legal rules governing the admission […]

Read the rest →

Submitting Claims for Off-label Prescriptions to Medicaid May Constitute Fraud

September 12, 2013

In my view, one of the most destructive developments in psychiatry in recent years is the prescribing of neuroleptic drugs to children.  Much of this prescribing is off-label, meaning that the prescribed use is not approved by the FDA.  Off-label drug prescribing is legal, however.  Once the FDA has approved a drug for one purpose, […]

Read the rest →

Do Psycho-Pharma Drugs Have Any Legitimate Function?

August 20, 2013

BACKGROUND In the last ten years or so, the anti-psychiatry movement has been gaining adherents, and has been growing more focused and more outspoken. But we are not a unified group.  I, for instance, take what I think would be considered a fairly extreme position.  I believe that there are no mental illnesses; that the […]

Read the rest →

Neuroleptics and Alzheimer’s Disease

August 12, 2013

I’ve mentioned the CATIE study before.  CATIE (Clinical Antipsychotic Trials of Intervention Effectiveness) was a NIMH-funded double blinded, randomized controlled trial comparing the effectiveness and side effects of newer-generation neuroleptics versus an older neuroleptic. CATIE-AD was a part of CATIE.  The AD stands for Alzheimer’s disease.  CATIE-AD was published in the New England Journal of Medicine […]

Read the rest →

Are The Second Generation Neuroleptics Good For the Brain?

August 5, 2013

There’s an editorial by Henry Nasrallah, MD, in last month’s edition of Current Psychiatry.  Dr. Nasrallah is the journal’s editor-in-chief.  The title of the article is Haloperidol clearly is neurotoxic.  Should it be banned?  Haloperidol is marketed under the brand name Haldol, but its patent has long expired, and a generic version is available and inexpensive. […]

Read the rest →

Agitation and Neuroleptics

July 20, 2013

Sandra Steingard, MD, is a practicing psychiatrist who from time to time posts articles on Robert Whitaker’s Mad in America website. Dr. Steingard apparently prescribes psychotropic drugs in her practice, but she is by no means a pill-for-every-problem practitioner, and her articles are always interesting and thought-provoking. Dr. Steingard posted A Paradox Revealed – Again […]

Read the rest →

The CAFE Study: Dr. Lieberman’s High Moral Ground

July 16, 2013

BACKGROUND The CAFE Study, conducted by Jeffrey Lieberman, MD, et al between 2002 and 2005, has been the subject of much comment.  Carl Elliott, in particular, has written extensively on the matter, including his article The Deadly Corruption of Clinical Trials in Mother Jones. In order to address the issues involved in the CAFE study, we […]

Read the rest →

Antipsychotics: A Euphemism for Neurotoxins

July 10, 2013

I guess everybody knows by now that Robert Whitaker spoke at the NAMI conference in San Antonio last Saturday (June 29).   You can view an outline of his speech, The Case for Selective Use of Antipsychotics here.  He spoke about the fact that for people who have been assigned a “diagnosis” of “schizophrenia,” long-term outcomes […]

Read the rest →

Neuroleptic Drugs and Children: Wrong Focus

July 8, 2013

It is a central theme of this website that psychiatry has done, and continues to do, a great deal of damage to people it claims to help. In my opinion, the damage done by neuroleptic drugs is among the most severe.  The increasing use of these products ought to be a huge cause for concern. […]

Read the rest →

Reduction in Neuroleptic Drugs Leads to Better Outcomes: Surprise?

July 6, 2013

BACKGROUND Mad in America ran an article (Reduction/Discontinuation of Antipsychotics Produces Higher Long-Term Recovery) on July 3, describing a piece of research on this topic which had been done in Holland. The original article, by Lex Wunderink, MD PhD et al, was published in the Journal of the American Medical Association Psychiatry (JAMA-P).  You can see […]

Read the rest →

Neuroleptics and Brain Shrinkage

June 29, 2013

Joanna Moncrieff, MD, has an article up on Mad in America.  It’s called Antipsychotics and Brain Shrinkage: An Update, and is dated June 19.  Joanna Moncrieff is the author of The Myth of the Chemical Cure, a widely-read book which challenges the entire concept of mental illness.  In the book Dr. Moncrieff also makes the […]

Read the rest →

Neuroleptics in Nursing Homes

June 20, 2013

Earlier this year, The American Society of Consultant Pharmacists published a report on the use of neuroleptic drugs in nursing homes.  According to this report, 25% of nursing home residents receive neuroleptic drugs. In general, the Centers for Medicare and Medicaid Services (CMS) consider these prescriptions appropriate only if the recipient is psychotic.  (Obviously we […]

Read the rest →

Akathisia

June 18, 2013

Melissa, a commenter on a recent post, asked if I would do a post on akathisia. Akathisia literally means inability to sit.  People with this problem typically pace for long periods, and if they do sit down, they continue to keep moving and shifting their position in the chair. In severity it can range from […]

Read the rest →

Psychiatric Drugs and Suicide

June 17, 2013

Courtesy of yobluemama2 on Twitter, I’ve come across an interesting article.  It’s called Psychiatric Drugs and Suicide, by Janne Larsson, a reporter.  It’s posted on PsychRights.org, a law project for psychiatric rights. The article focuses on suicides committed in Sweden in 2006-2007, and the proportions of victims who had taken psychiatric drugs in the period […]

Read the rest →

Neuroleptics for Children

May 18, 2013

Of all the evils perpetrated by American psychiatry in the past 60 years, the administration of neuroleptic drugs to children is arguably the worst.  And it is a practice that is growing each year. The essential purpose of these drugs is to make people more docile and more easily managed by destroying brain tissue.  The […]

Read the rest →

Talk Therapy for Schizophrenia

May 14, 2013

There’s an interesting article on Vermont’s Seven Days.  It’s called Burlington’s HowardCenter Tries a New Approach to Treating Mental Illness: More Talk, Fewer Meds.  You can see it here.  (Thanks to Steven Coles on Twitter for the link.) Apparently Vermont’s Department of Mental Health is promoting a “new” kind of treatment for psychosis:  talk therapy.  […]

Read the rest →

“You must take these pills for life.” Or is it for death?

May 12, 2013

There’s an important article (here) on Monica Cassani’s website BeyondMeds in which she tackles the myth that once a person has been assigned a “diagnosis” of schizophrenia, he/she must take neuroleptics for life. Here’s a quote: “Unfortunately, at this juncture in history many people who get labeled with psychiatric illness these days do not have […]

Read the rest →

Neuroleptics Increase the Risk of Osteoporosis

April 27, 2013

We’ve all known for a long time that neuroleptic drugs damage brain cells.  But now it seems clear that they also increase the risk of osteoporosis and consequently bone fractures. There’s an article about this in the International Journal of Endocrinology, dated March 2013.  It’s titled Osteoporosis Associated with Antipsychotic Treatment in Schizophrenia, and was […]

Read the rest →

The Power of Words to Shape Attitudes

April 21, 2013

I recently wrote a post called:  Do Major Tranquilizers Make Things Worse?  The post was based on a study by Drs. Harrow and Jobe in which they speculated that the high relapse rate of “schizophrenics” who stop taking their drugs may have more to do with drug withdrawal than the supposed drug efficacy. Monica, at […]

Read the rest →

Tardive Dyskinesia

March 7, 2013

In the late 80’s, I worked for a while in a State Hospital in West Virginia.  Clients would arrive on 72-hour holding committals from the counties, and if the psychiatrist felt that the client needed to stay longer than that (which was almost always the case), then either the client had to convert to voluntary […]

Read the rest →